| scholarly article | Q13442814 |
| P50 | author | Dong Zhang | Q59687621 |
| P2093 | author name string | Khosrow Rezvani | |
| Hongmin Wang | |||
| Ammara Abdullah | |||
| Sanam Sane | |||
| Jessica L Freeling | |||
| Kate A Branick | |||
| P2860 | cites work | The UBXN1 protein associates with autoubiquitinated forms of the BRCA1 tumor suppressor and inhibits its enzymatic function | Q24305086 |
| The RasGAP proteins Ira2 and neurofibromin are negatively regulated by Gpb1 in yeast and ETEA in humans | Q27934997 | ||
| Activation of p53 and the pro-apoptotic p53 target gene PUMA during depolarization-induced apoptosis of chromaffin cells | Q28268239 | ||
| Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer | Q28274188 | ||
| UBXD4, a UBX-containing protein, regulates the cell surface number and stability of alpha3-containing nicotinic acetylcholine receptors | Q28507709 | ||
| Sp1 expression regulates lung tumor progression. | Q30524654 | ||
| Apoptosis induced by staurosporine alters chaperone and endoplasmic reticulum proteins: Identification by quantitative proteomics | Q33293118 | ||
| Signaling pathways in early onset sporadic breast cancer of patients in Indonesia. | Q33374250 | ||
| Mortalin/GRP75 binds to complement C9 and plays a role in resistance to complement-dependent cytotoxicity | Q33652205 | ||
| Difluorinated-curcumin (CDF): a novel curcumin analog is a potent inhibitor of colon cancer stem-like cells | Q33772604 | ||
| Where do we stand with 5-fluorouracil? | Q33800905 | ||
| Immuno nanoparticles integrated electrical control of targeted cancer cell development using whole cell bioelectronic device | Q33935492 | ||
| Differences in integrin expression and signaling within human breast cancer cells | Q33959863 | ||
| Association of TP53 mutational status and gender with survival after adjuvant treatment for stage III colon cancer: results of CALGB 89803 | Q34004105 | ||
| Identification and functional characterization of nuclear mortalin in human carcinogenesis. | Q34138936 | ||
| Detecting treatment response in a model of human breast adenocarcinoma using hyperpolarised [1-13C]pyruvate and [1,4-13C2]fumarate | Q34344210 | ||
| Predictive biomarkers of chemotherapy efficacy in colorectal cancer: results from the UK MRC FOCUS trial | Q46570394 | ||
| Resveratrol displays converse dose-related effects on 5-fluorouracil-evoked colon cancer cell apoptosis: the roles of caspase-6 and p53. | Q46581064 | ||
| Mortalin and DJ-1 coordinately regulate hematopoietic stem cell function through the control of oxidative stress | Q46970679 | ||
| Elevated levels of mortalin expression in human brain tumors. | Q48570877 | ||
| Epidemiology of colorectal cancer | Q56994980 | ||
| Withanone binds to mortalin and abrogates mortalin–p53 complex: Computational and experimental evidence | Q59192509 | ||
| p53 expression measured by flow cytometry. A comparison of three monoclonal antibodies and the relationship with grade and DNA ploidy in breast cancer | Q71729258 | ||
| Mortalin is over-expressed by colorectal adenocarcinomas and correlates with poor survival | Q80976046 | ||
| Crosstalk between Raf/MEK/ERK and PI3K/AKT in suppression of Bax conformational change by Grp75 under glucose deprivation conditions | Q85028293 | ||
| Ubiquitin-associated (UBA) domain in human Fas associated factor 1 inhibits tumor formation by promoting Hsp70 degradation | Q34372429 | ||
| Mortalin-p53 interaction in cancer cells is stress dependent and constitutes a selective target for cancer therapy | Q35092706 | ||
| Vinblastine-induced apoptosis is mediated by discrete alterations in subcellular location, oligomeric structure, and activation status of specific Bcl-2 family members | Q35160453 | ||
| Dissecting the role of the mitochondrial chaperone mortalin in Parkinson's disease: functional impact of disease-related variants on mitochondrial homeostasis | Q35819806 | ||
| Intrinsic tumour suppression | Q35953133 | ||
| Low expression of chloride channel accessory 1 predicts a poor prognosis in colorectal cancer | Q36302699 | ||
| Establishment of a human colorectal cancer cell line P6C with stem cell properties and resistance to chemotherapeutic drugs | Q36907415 | ||
| Vitamin D signalling pathways in cancer: potential for anticancer therapeutics | Q36919979 | ||
| Hypotensive natural products: current status | Q37232741 | ||
| A mortalin/HSPA9-mediated switch in tumor-suppressive signaling of Raf/MEK/extracellular signal-regulated kinase | Q37264396 | ||
| Cytoplasmic functions of the tumour suppressor p53. | Q37466228 | ||
| Targeting GRP75 improves HSP90 inhibitor efficacy by enhancing p53-mediated apoptosis in hepatocellular carcinoma | Q37490724 | ||
| Ubiquitin-like (UBX)-domain-containing protein, UBXN2A, promotes cell death by interfering with the p53-Mortalin interactions in colon cancer cells | Q37680211 | ||
| RETRACTED ARTICLE: JNK confers 5-fluorouracil resistance in p53-deficient and mutant p53-expressing colon cancer cells by inducing survival autophagy | Q37702749 | ||
| Mitochondria: a promising target for anticancer alkaloids | Q38131568 | ||
| Targeting cancer stem cells to suppress acquired chemotherapy resistance | Q38149736 | ||
| Nonsteroidal anti-inflammatory drug activated gene-1 (NAG-1) modulators from natural products as anti-cancer agents. | Q38188352 | ||
| Colon cancer: cancer stem cells markers, drug resistance and treatment | Q38280180 | ||
| Overexpression of Mortalin in hepatocellular carcinoma and its relationship with angiogenesis and epithelial to mesenchymal transition | Q39067007 | ||
| Induction of mutant p53-dependent apoptosis in human hepatocellular carcinoma by targeting stress protein mortalin. | Q39619016 | ||
| Tumor suppression by apoptotic and anti-angiogenic effects of mortalin-targeting adeno-oncolytic virus | Q39684064 | ||
| Dual mechanisms of sHA 14-1 in inducing cell death through endoplasmic reticulum and mitochondria. | Q39832035 | ||
| Gender differences in colorectal cancer incidence, mortality, hospitalizations and surgical procedures in Canada | Q40097375 | ||
| A more efficient RNAi inducible system for tight regulation of gene expression in mammalian cells and xenograft animals | Q40110405 | ||
| Stress chaperones, mortalin, and pex19p mediate 5-aza-2' deoxycytidine-induced senescence of cancer cells by DNA methylation-independent pathway. | Q40153665 | ||
| Activation of wild type p53 function by its mortalin-binding, cytoplasmically localizing carboxyl terminus peptides. | Q40370477 | ||
| Mortalin imaging in normal and cancer cells with quantum dot immuno-conjugates | Q40598658 | ||
| Contribution of functional voltage‐gated Na+ channel expression to cell behaviors involved in the metastatic cascade in rat prostate cancer: I. lateral motility | Q40653900 | ||
| Activation of the Fas pathway independently of Fas ligand during apoptosis induced by camptothecin in p53 mutant human colon carcinoma cells | Q40811052 | ||
| Effects of voltage-gated ion channel modulators on rat prostatic cancer cell proliferation: comparison of strongly and weakly metastatic cell lines | Q40872588 | ||
| Induction of apoptosis in prostatic tumor cell line DU145 by staurosporine, a potent inhibitor of protein kinases | Q41182268 | ||
| Acute and delayed apoptosis induced by thymidine deprivation correlates with expression of p53 and p53-regulated genes in colon carcinoma cells. | Q41198220 | ||
| MKT-077, a novel rhodacyanine dye in clinical trials, exhibits anticarcinoma activity in preclinical studies based on selective mitochondrial accumulation. | Q41235761 | ||
| Veratridine induces apoptotic death in bovine chromaffin cells through superoxide production | Q41823292 | ||
| Evaluating new therapies in gastrointestinal stromal tumor using in vivo molecular optical imaging | Q41963175 | ||
| Superoxide anions mediate veratridine-induced cytochrome c release and caspase activity in bovine chromaffin cells | Q42620684 | ||
| Inactivation of tumor suppressor p53 by mot-2, a hsp70 family member. | Q42825164 | ||
| Selective toxicity of MKT-077 to cancer cells is mediated by its binding to the hsp70 family protein mot-2 and reactivation of p53 function. | Q42832610 | ||
| Topiramate and phenytoin anti-immobility effect in the mice forced swimming test is reversed by veratrine: Implication for bipolar depression treatment | Q43297492 | ||
| Breast tumor immunophenotype of BRCA1-mutation carriers is influenced by age at diagnosis | Q43670876 | ||
| Resistance of colon cancer cells to long-term 5-fluorouracil exposure is correlated to the relative level of Bcl-2 and Bcl-X(L) in addition to Bax and p53 status | Q43938032 | ||
| Differential cytostatic and apoptotic effects of ecteinascidin-743 in cancer cells. Transcription-dependent cell cycle arrest and transcription-independent JNK and mitochondrial mediated apoptosis. | Q44116130 | ||
| Src activation regulates anoikis in human colon tumor cell lines | Q44208143 | ||
| Mortalin is a prognostic factor of gastric cancer with normal p53 function | Q44263599 | ||
| Chromosome copy number analysis in screening for prognosis-related genomic regions in colorectal carcinoma | Q44868614 | ||
| P433 | issue | 27 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 23561-23581 | |
| P577 | publication date | 2015-09-01 | |
| P1433 | published in | Oncotarget | Q1573155 |
| P1476 | title | A plant alkaloid, veratridine, potentiates cancer chemosensitivity by UBXN2A-dependent inhibition of an oncoprotein, mortalin-2 | |
| P478 | volume | 6 |
| Q36190104 | Nucleocytoplasmic Translocation of UBXN2A Is Required for Apoptosis during DNA Damage Stresses in Colon Cancer Cells. |
| Q37625726 | Relevance of mortalin to cancer cell stemness and cancer therapy. |
| Q36674097 | Structural studies of UBXN2A and mortalin interaction and the putative role of silenced UBXN2A in preventing response to chemotherapy |
| Q28069036 | UBXD Proteins: A Family of Proteins with Diverse Functions in Cancer |
| Q58766271 | UBXN2A enhances CHIP-mediated proteasomal degradation of oncoprotein mortalin-2 in cancer cells |
Search more.